Clonidine vs Veozah for Hot Flashes: Which One Fits You?

Don’t pick either from a web page if you…

• Have liver, kidney, blood-pressure, heart-rhythm, or fainting concerns.
• Take other medicines that haven’t been checked for interactions.
• Are already on clonidine and thinking about stopping — never stop it suddenly.

For moderate-to-severe menopause hot flashes, Veozah is the more evidence-backed choice of the two. It’s FDA-approved for hot flashes, was studied in large trials, and is recommended by The Menopause Society (2023). Clonidine can help some women, but its benefit is modest, it’s used off-label, and that same 2023 guideline does not recommend it.

One thing to keep in mind:there is no study that tested clonidine directly against Veozah. When we say Veozah works better, we’re comparing each drug’s own trials against a placebo, plus what expert guidelines say — not a head-to-head race. Any page showing you a precise “X% better” stat between these two drugs is guessing.

Clonidine and Veozah are both non-hormonal, but completely different medicines. Clonidine is an old blood-pressure drug (an “alpha-2 agonist”) that happens to calm hot flashes. Veozah (a “neurokinin 3 receptor antagonist”) was built for one job: to block a brain signal that triggers hot flashes during menopause.

⚠ The one honest downside you’re probably worried about

Veozah’s biggest drawback is real: in December 2024, the FDA added a “Boxed Warning” — its most serious warning — for rare but serious liver injury.You’ll need a liver blood test before you start and again at months 1, 2, 3, 6, and 9. That’s six checks in your first nine months. Clonidine has no warning like that and no lab schedule. But here’s the honest flip side: that monitoring isn’t there because Veozah is “stronger” — it’s there because a small number of serious liver-injury cases were reported after the drug was approved. For most women whose doctor clears the contraindications, the real question is: is Veozah’s much stronger evidence worth the extra monitoring?

Based on the trial evidence, yes — though the two were never tested against each other. In its main trials, Veozah cut moderate-to-severe hot flashes by about 2.5 more per day than a placebo. Clonidine’s benefit in older, smaller studies is modest and harder to pin to one number. Both are less effective than hormone therapy, which is still the most effective treatment for hot flashes.

Why we won’t give you a “Veozah is X% better” number: because it would be made up. The two drugs were never tested against each other in the same study. Their trials used different women, different symptom levels, and different rules. Any page that hands you a precise head-to-head success rate is guessing.

Veozah was developed and reviewed specifically to treat menopause hot flashes, so the FDA approved it for that use. Clonidine was created as a blood-pressure medicine. Its hot-flash use grew out of older, separate research — doctors can prescribe it off-label, but the FDA has never approved it for menopause.

⚠ Veozah is still FDA-approved for moderate-to-severe hot flashes, but it carries a Boxed Warning for rare but serious liver injury and requires liver blood tests before you start and at months 1, 2, 3, 6, and 9. Anyone with cirrhosis, severe kidney disease, or certain interacting medicines should not take it.

Stop Veozah immediately and seek medical care (including liver blood tests) if you notice: new tiredness, loss of appetite, nausea or vomiting, itching, yellowing of skin or eyes, pale-colored stool, dark urine, or pain in the upper-right belly.

Clonidine’s big risk isn’t the liver — it’s blood pressure. It can drop your blood pressure too low (dizziness, fainting) and, you should never stop it suddenly, because that can cause a fast, dangerous rebound in blood pressure (MedlinePlus). A prescriber gives you a step-down plan when it’s time to stop.

Veozah is off the table if you have known cirrhosis, severe or end-stage kidney disease, or take a CYP1A2 inhibitor medicine (such as fluvoxamine or cimetidine). Clonidine has a different set of watch-outs centered on blood pressure, heart rate, fainting, kidney function, and other sedating or blood-pressure medicines.

Clonidine can modestly reduce hot flashes, but it’s used off-label and The Menopause Society’s 2023 guidance does not recommend it, citing limited benefit and side effects. Its downsides matter: dry mouth, drowsiness, dizziness, low blood pressure, and a rebound in blood pressure if stopped abruptly. It’s also on the Beers Criteria, which flags extra caution in adults 65 and older.

Why the guideline stepped back from it: In 2023, The Menopause Society reviewed the evidence and put clonidine on its “not recommended”list for hot flashes — the benefit was modest and better-tolerated options existed. A prescriber may still reach for it (usually when very low cost is the deciding factor), but it’s no longer a first choice.

Without insurance, the gap is huge. Generic clonidine tablets can run just a few dollars a month, while Veozah has a list price of $583.50 for 30 tablets (January 2026) because it’s brand-only with no generic. But with commercial insurance, Veozah’s savings card can bring it to as little as $0 the first month and about $30 per refill — so your real cost depends heavily on your coverage.

How to actually lower Veozah’s cost:

• The savings card(commercial insurance only): $0 first month, then ~$30/refill, up to $4,000-a-year max. Can’t be used for cash-pay patients or those on Medicare or Medicaid.
• Patient assistance for uninsured women — Astellas program (eligibility required).
• Prior authorization — many plans require your doctor to justify it first. See our Veozah prior authorization guide for what to expect.

Veozah has a simple pill schedule — one 45 mg tablet a day — but a demanding monitoring schedule with six liver tests in nine months. Clonidine looks simpler and cheaper day to day, but blood pressure needs watching, the dose may need adjusting, and stopping requires a planned taper.

Ask about a different option if:

• Veozah is contraindicated or unaffordable for you.
• Clonidine’s blood-pressure or drowsiness effects are a problem.
• You’re 65 or older — ask your prescriber to weigh dizziness, low blood pressure, slow heart rate, and fall risk.
• You haven’t been told whether hormone therapy is even an option for you.

The choice isn’t always clonidine or Veozah. Several other non-hormonal medicines are actually recommended over clonidine — and hormone therapy is the most effective option for women who can take it (Menopause Society, 2023).

This page covers hot flashes and night sweats. A drug chosen for those won’t automatically fix vaginal dryness, painful sex, low libido, or mood — those need their own plan.

The best questions test the diagnosis, the reason for this specific drug, the safety screen, the monitoring plan, the check-in timing, and the full cost. Bring your complete medicine and supplement list.

Patient reviews can show you what people actually struggle with— cost, incomplete relief, side effects — but they can’t prove a drug works or is safe, and they shouldn’t outweigh the trials and guidelines above. Ratings are self-selected, so read them for context, not proof.

We built this under The HRT Index Verification Standard— tracing every claim to a current label, FDA notice, clinical guideline, trial, or dated price. This is editorial research, not medical advice, and it was not reviewed by a clinician. We don’t invent scores, and we won’t pretend two separate trials are a head-to-head study.

Last verified: July 14, 2026. Spot a claim that looks out of date? Our editorial team page explains how to reach us.

Update log

July 14, 2026 — Initial verification of FDA labels, trial data, guideline recommendations, pharmacy prices, and savings terms.